There is a sanctuary hidden beyond the veil of the cosmos, a place where gravity surrenders to rhythm and light is born from sound. It is not a heaven built of pearl or gold, but of swara and laya a boundless, breathing architecture of pure melody. In this eternal Mehfil, time does not march; it dances. And here, the greatest architects of human emotion have gathered to sing the universe into bloom.

Imagine standing at the threshold of this celestial grandstand. The air itself hums. Imagine a realm where time holds no sway, where the skies are not made of clouds, but of woven melodies, and the air breathes with the rhythm of a billion beating hearts. There is a place beyond our mortal sight a celestial grandstand, a heavenly Mehfil where the greatest architects of Indian music gather to perform a symphony that echoes across eternity.

They say music never dies, but what happens to the voices that birthed it? They ascend. And in this divine amphitheater, a reunion of unimaginable magic is taking place.

It begins with a single, luminescent note, fragile yet unbreakable. It is Lata Mangeshkar. She sits cloaked in the serenity of moonlight, her voice the silver thread that stitches the stars together. Beside her, crackling with the vibrant, uncontainable energy of a solar flare, is Asha Bhosle. Together, they are the eternal duality of the cosmos the calm and the storm, the devotion and the desire their voices intertwining to create a tapestry of infinite grace.

As their melody swells, the foundation of heaven is laid by the titans of the golden age. Mohammed Rafi breathes out, and his voice becomes the gentle, compassionate wind that cradles the soul, so pure it brings the angels to their knees. A sudden, joyous gust sweeps through it is the irrepressible spirit of Kishore Kumar, whose yodels and laughter paint the cosmic sky in wild, rebellious colors. Grounding this wildness is the sacred geometry of Manna Dey, his classical mastery building invisible temples of flawless pitch, while the towering, clarion call of Mahendra Kapoor echoes like the victorious sunrise over the horizon. Beneath them all, deep and resonant as an ancient, undisturbed ocean, rolls the majestic baritone of Hemant Kumar.

But perfection alone cannot hold the human spirit; heaven, too, needs the exquisite vulnerability of a breaking heart. From the velvet shadows steps Jagjit Singh. With a gentle strum, his voice pours out like warm, liquid amber, holding all the unspoken sorrow and longing of a thousand lifetimes. He is answered by the tender, soothing cadence of Pankaj Udhas, turning the ache of separation into a sublime, spiritual ecstasy. Through their ghazals, they remind eternity that the most beautiful part of being alive is the capacity to feel.

The cosmos demands grandeur, and so the sky splits open to the staggering, all-encompassing voice of S.P. Balasubrahmanyam. His notes cascade like a golden waterfall, vast enough to drown the galaxies, yet gentle enough to bless a single falling leaf. And weaving through this grandeur is a pulse of pure, unadulterated joy Bappi Lahiri, cloaked in his radiant aura, injecting the heavens with a synthesized, driving rhythm that makes the constellations themselves want to dance.

In that celestial mehfil, where time dissolves into a timeless symphony, a new burst of unbridled energy has ignited the stars. It is the arrival of our beloved Pancham Da, the revolutionary R.D. Burman. He steps into the spotlight, not as a calm presence, but as a whirlwind of sonic liberation. His infectious grin, wide as the horizon, promises a disruption that heaven didn’t know it needed. Clad in a shirt that seems woven from psychedelic rainbows and holding a chromatic mouth organ like a royal scepter, he is the avatar of musical rebellion. His spirit, the eternal ‘Rockstar,’ infuses the ancient echoes with pulsating beats and daring basslines, making the celestial domes tremble with a rhythm that bridges a hundred generations of youth. With a mischievous wink, he is not just part of the symphony, he is its wildly, wonderfully unpredictable heart, forever playing the melody of freedom and defining the very soul of the cosmos. He has not just joined the gathering, he has set it on fire, ensuring that every note played from this day forth carries the undeniable, effervescent magic of Pancham.

Then comes the raw, bleeding edge of passion. The skies shimmer as KK (Krishnakumar Kunnath) unleashes his spirit. His voice is a soaring comet, burning with the fierce, unfiltered urgency of youth, of first loves and final goodbyes. It is a voice that rips the heart open and pours light into the wound. Matching this primordial energy is the piercing, earth-shattering cry of Zubeen Garg, his melodies carrying the wild, untamed essence of the mountains and rivers, a folk-infused tempest that bridges the mortal earth with the divine sky.

And what holds this staggering universe of sound together? The heartbeat of the cosmos itself. Fingers moving faster than light, Zakir Hussain commands the tabla. His hands do not just play an instrument; they dictate the rotation of planets, the pulse of quasars, creating a rhythm so transcendent it weaves the living and the ascended into a single, breathing entity.

This is not just a concert but it is a confluence of immortals. They sit together some who have crossed the veil, others whose spirits simply transcend it bound by the one truth that outlives flesh and bone, Music is the soul’s native tongue.

For us, wandering the earth below, the silence they leave in our quiet moments can feel like an ache. But we are not abandoned. If you close your eyes, quiet your mind, and listen to the spaces between your own heartbeats, you will hear them. You will hear the symphony of the heavens, pouring down like rain.

They are there, keeping the universe in tune, preparing the grandest crescendo for the day we all finally come home. We will meet again, the music promises. We will meet in the melody.

The ultimate culmination of human emotion. From the classical to the contemporary, from the soulful to the spectacular, these legends sit together not as competitors, but as cosmic collaborators.

They are rehearsing for the day we all finally return home.

As the final, harmonious chord of this heavenly gathering rings out, it carries a simple, powerful promise to all of us who have ever found solace in their songs, Through the music, we are never truly apart. Keep listening. We will meet again.

Artificial Intelligence is already entering courtrooms. But most judges have little formal training or clear guidance. The document “AI Essentials for Judges” by UNESCO (2026) emphasizes that AI is a powerful tool to enhance efficiency, accessibility, and transparency in the judicial system. However, it must be used responsibly, with safeguards to protect confidentiality, human rights, and judicial independence. Judges and legal professionals are encouraged to adopt good practices, undergo training, and consult UNESCO’s guidelines for ethical AI use in courts.

Since 2013, UNESCO has been involved in the training of judicial actors as part of its Judges Initiative. In total, more than 36,000 judicial operators (judges, prosecutors, clerks, court officials, lawyers) from more than 160 countries have been engaged. In 2021, UNESCO continued this momentum by launching the AI & Rule of Law programme to meet a growing demand for capacity building and support on the challenges of technology in the judicial sector. UNESCO developed a Global Toolkit on AI and the Rule of Law for the Judiciary (also available in Arabic, French, and Spanish) that serves as a foundation for its training programme around the world. – UNESCO

The document “AI Essentials for Judges” by UNESCO (2026) provides an overview of artificial intelligence (AI) and its implications for the judicial sector. It is designed to inform judges, prosecutors, court staff, and lawyers about AI, its uses, benefits, risks, and ethical considerations.

Below are the key points:

1. Artificial Intelligence (AI): Technology that performs repetitive, time-consuming tasks by processing data and mimicking intelligent behavior, including reasoning, learning, and decision-making.

• Generative AI (GenAI): AI that creates content (text, images, video, code) based on large datasets and user prompts.

2. Development & Use of AI in the Judicial Sector Guiding AI Development: Courts can adopt AI by creating strategies, mapping court data, digitizing documents, and collaborating with stakeholders while maintaining control over data and tools.

Applications of AI

• Administrative Support: Automating routine tasks like file sorting, calendar management, and document transcription.
• Document Analysis: Searching, summarizing, translating, and cross-referencing legal documents.
• Decision Support: Assisting judges with data analysis, case law review, and drafting decisions. Improving
• Case Management: AI can automate routine cases, reduce delays, and streamline workflows while maintaining judicial oversight.

3. Use of AI by Judges Steps Before Using AI: Judges should check institutional policies, review ethical guidelines, understand the tool, clarify liability, and invest in training. Good

• Practices: Judges should exercise vigilance, safeguard confidentiality, verify AI outputs, ensure transparency, and report issues.

4. Potential Benefits for Litigants AI can improve access to justice by: Providing clear legal guidance through tools like chatbots.

• Automating simple procedures to reduce costs and delays.
• Simplifying court decisions with plain-language summaries.
• Supporting individuals with low literacy or language barriers through tailored interfaces and translation tools.

5. Risks Confidentiality and Cybersecurity: AI can pose risks like data leaks, profiling of judges, and threats to judicial independence. Courts must regulate data access, ensure secure systems, and avoid public Wi-Fi.

• Ethical and Human Rights Risks: Risks include algorithmic bias, loss of privacy, over-reliance on AI, and threats to human rights. Human rights impact assessments are essential before and after AI deployment.
• AI Hallucinations: Judges must verify AI outputs against laws and case law to detect inaccuracies. AI Replacing Judges: AI cannot replace human judges due to its inability to perform nuanced legal reasoning and ethical decision-making.

6. Preventive and Corrective Actions Bar Associations: Their involvement is crucial to ensure ethical and fair use of AI in legal proceedings.

Appeal Mechanisms: Litigants must have access to human review and transparent appeal procedures for AI-based decisions. EU regulations like GDPR and the AI Act provide frameworks for such mechanisms.

The document references various UN reports and UNESCO initiatives, including the AI & Rule of Law programme, MOOCs, and toolkits to support judiciary in understanding and using AI responsibly. 

Rajdeep Dam

Director,

Club for UNESCO Silchar,

Silchar, Assam, India

Regenerative medicine is no longer limited to repairing tissues. It is moving toward building fully functional organs. One of the most exciting developments in this field is the bioengineering of kidney tissue that can filter blood and produce urine like fluid under laboratory conditions. While a transplant ready lab grown kidney does not yet exist, the science has moved far beyond theory.

This is not science fiction. It is the result of years of research across leading institutions such as Harvard University, University of California, Davis, and collaborative global biotech laboratories. Findings have appeared in peer reviewed platforms including BMC Nephrology and Nature Reviews Nephrology.

What it means, and where the science stands today

Chinese scientists in Shanghai have achieved a major breakthrough in regenerative medicine by successfully growing a functional human kidney in a lab that filters blood, balances electrolytes, and produces urine. Using stem cell-derived organoids and a biodegradable hydrogel scaffold, this bioengineered organ mimicked natural kidney function for over 60 hours, marking a significant step toward addressing the global donor shortage.

Key details of this achievement include:

Functionality: The lab-grown kidney functions similarly to a natural organ, capable of separating waste from blood and returning clean plasma.

Structure: Researchers utilized advanced tissue engineering, seeding stem cells onto a specialized scaffold to form crucial kidney structures, including nephrons.

Significance: While still in experimental stages, this technology could eventually provide transplantable organs that, being derived from a patient’s own cells, could eliminate the need for immune-suppressing drugs.

Performance: The organoid “assembloids” (combined nephron and collecting duct components) demonstrated the ability to respond to hormonal signals, adjusting water and salt retention, similar to a real kidney.

Future outlook: Though fully transplantable human kidneys are not yet in clinical use, this milestone brings the medical community closer to replacing dialysis and saving patients with chronic kidney disease.

That is an incredible milestone in regenerative medicine! While we’ve seen “organoids” (miniature, simplified versions of organs) for several years, moving toward a fully functional, lab-grown kidney represents a massive leap toward solving the global organ donor shortage. 

Why this specific breakthrough is such a game-changer and what the current “state of the science” looks like.

The engineering challenge

The kidney is one of the most complex organs to replicate because it isn’t just a filter; it’s a sophisticated chemical plant. To work, a lab-grown kidney must master three distinct phases: 

Filtration: Removing waste from the blood through the glomerulus.

Reabsorption: Taking back necessary nutrients and water so you don’t become dehydrated.

Excretion: Channelling the waste (urine) out of the body through a complex network of tubes. 

How scientists are doing it

Current breakthroughs generally rely on two primary methods: 

3D bioprinting: Using “bio-ink” made of living cells to print the organ’s structure layer by layer, including the intricate vascular system (blood vessels) needed to keep the tissue alive.

Decellularization: Taking an existing organ (like a pig kidney or a damaged human kidney), stripping away all the original cells to leave a “ghost scaffold” of connective tissue, and then “re-seeding” it with the patient’s own stem cells. 

The implications of a functional, urine-producing lab kidney are profound: 

No more rejection: Because the organ is grown from the patient’s own stem cells, the immune system recognizes it as “self,” potentially eliminating the need for lifelong immunosuppressant drugs.

End of dialysis: Dialysis is grueling and only performs about 10-15% of a normal kidney’s function. A bioengineered organ could restore a patient to near-full health.

The “Waiting List” problem: Thousands of people die every year waiting for a transplant. Lab-grown organs could eventually be produced “on demand.” 

The global kidney crisis

Chronic kidney disease affects more than 850 million people worldwide. Many patients progress to end stage renal disease, where survival depends on dialysis or kidney transplantation. Dialysis is life sustaining but not a cure. Transplantation is limited by donor shortages, long waiting lists, immune rejection, and lifelong immunosuppression.

The gap between demand and availability has driven scientists to explore organ regeneration, bioengineering, and stem cell technology as long term solutions.

What is a bioengineered kidney

A bioengineered kidney is not a single technique but a combination of advanced biological and engineering strategies. The goal is to recreate the kidney’s complex architecture and functionality.

The process typically involves three major components:

1. Stem cells

Stem cells are the body’s master repair cells. Researchers use pluripotent stem cells, often induced pluripotent stem cells derived from adult tissues, and guide them to differentiate into kidney specific cell types such as podocytes, tubular cells, and endothelial cells.

2. Scaffolds

A scaffold acts as the structural backbone of the organ. It can be:

• A decellularized kidney from a donor organ, where all cells are removed but the extracellular matrix remains intact
• A synthetic biodegradable framework engineered to mimic kidney architecture

The scaffold provides physical guidance for cells to organize properly.

3. 3D bioprinting

3D bioprinting allows researchers to precisely place cells and biomaterials layer by layer. This is critical for constructing nephrons, the functional filtering units of the kidney, along with tiny ducts and vascular channels that allow fluid flow.

What has actually been achieved

Several major milestones have already been demonstrated:

Kidney organoids

Researchers have successfully grown kidney organoids, miniature simplified kidney structures derived from stem cells. These organoids:

• Develop nephron like units
• Show filtration characteristics
• Respond to toxins and drugs similarly to human kidneys

Although small and immature compared to a full organ, they represent a functional biological model.

Perfusable vascular systems

A major breakthrough has been the creation of perfusable channels within engineered tissue. Scientists have demonstrated that:

• Engineered ducts can carry urine like fluid
• Lab grown kidney structures can filter waste molecules under controlled conditions
• Blood vessel networks can integrate with host circulation in animal studies

This is critical because without vascularization, no organ can survive after transplantation.

Bioartificial kidney devices

Parallel to organ growth research, implantable bioartificial kidney devices are under development. These combine silicon filtration membranes with living kidney cells to replicate natural filtration and reabsorption processes.

What it can do today

In laboratory and experimental settings, bioengineered kidney tissue can:

• Filter blood like fluid
• Produce urine like output
• Mimic early stage kidney functions
• Serve as a testing platform for drug toxicity
• Model genetic kidney diseases

However, it is important to be clear, there is no fully transplant ready lab grown human kidney functioning independently inside a human patient yet.

What it solves

1. Solving organ shortage

A successful lab grown kidney would eliminate the dependency on donor organs.

2. Reducing rejection

If generated from a patient’s own stem cells, the risk of immune rejection could be dramatically reduced.

3. Transforming drug testing

Kidney organoids already provide more accurate platforms for studying nephrotoxicity compared to animal models.

4. Personalized medicine

Scientists can grow patient specific kidney tissue to study inherited kidney diseases and test targeted therapies.

The scientific challenges ahead

Despite remarkable progress, several major hurdles remain:

Scaling up

Current organoids are tiny. A full human kidney contains about one million nephrons. Replicating this complexity at full scale is extremely challenging.

Maturation

Lab grown tissues often resemble fetal stage kidneys. They must mature to adult functionality before clinical transplantation becomes viable.

Vascular integration

Although perfusion systems have improved, integrating a bioengineered kidney with full systemic circulation remains complex.

Long term stability

Researchers must demonstrate long term durability, filtration efficiency, hormonal regulation, and safety.

The role of leading research institutions

Research teams from Harvard University have pioneered stem cell differentiation protocols and organoid development. Scientists at University of California, Davis have contributed to regenerative scaffolding and translational research.

Findings published in journals such as BMC Nephrology and Nature Reviews Nephrology detail advances in nephron modeling, vascularization strategies, and regenerative engineering techniques.

This global collaboration underscores that the field is moving steadily forward, grounded in peer reviewed science.

Are we close to human transplants

Experts suggest that while organoids and bioengineered tissue are advancing rapidly, a fully functional transplant ready kidney may still require years of development and clinical testing.

The pathway typically includes:

• Preclinical animal studies
• Safety validation
• Regulatory approval
• Carefully monitored human trials

However, progress over the last decade has been faster than many predicted.

Kidney bioengineering represents a broader shift in medicine. The focus is moving from managing organ failure to rebuilding organs.

A new era in regenerative medicine

This breakthrough symbolizes more than a lab experiment. It reflects:

• Advances in stem cell biology
• Precision biofabrication
• Tissue vascular engineering
• Cross disciplinary collaboration

Science is not just extending life. It is redefining what is biologically possible.

Final thoughts

The phrase kidney grown successfully should be understood accurately. Scientists have successfully grown functional kidney tissue capable of filtration in laboratory environments. They have engineered structures that mimic real kidney behavior. They have demonstrated perfusion and urine like output under controlled conditions.

But a complete, transplant ready, fully mature human kidney grown entirely in a lab is still under development.

Even so, this progress represents hope in action. For millions waiting for dialysis freedom. For families searching for donor matches. For a future where organ failure does not mean lifelong dependence on machines.

Regenerative medicine is not about hype. It is about steady, measurable scientific advancement.

And for the first time in history, building a human kidney is no longer impossible.

---

Research articles and references, for further deep dives

Kidney organoid development

• Takasato et al, “Kidney organoids from human iPS cells contain multiple lineages” (Nature, 2015) — seminal work showing human pluripotent stem cells can form kidney-like structures.
• Morizane & Bonventre, “Kidney Organoids: A Translational Journey” (Trends in Molecular Medicine) — review of organoid models and relevance to human disease.
• McMahon, “Recent Advances in Kidney Development, Organoid Generation and Regeneration” — discusses developmental biology insights applied to organ engineering.

Scaffolding and tissue engineering

• Ross et al, “Decellularized kidney scaffolds: an engineering and biological perspective” — exploration of using decellularized matrices for organ regeneration.
• Song et al, “Regeneration and Experimental Orthotopic Transplantation of a Bioengineered Kidney” (Nature Medicine, 2013) — early proof-of-concept for bioengineered organ transplants in animals.

3D bioprinting and vascularization

• Homan et al, “Bioprinting of 3D kidney tissues with integrated vasculature” — describes methods for printing kidney-like tissues with flow channels.
• Zhang & Yu, “Engineering of Kidney Tissue with Vascular Networks” (Advanced Healthcare Materials) — focus on microvascular networks integration.

Reviews and clinical perspectives

Regenerative medicine for kidneys

• Little et al, “Human Kidney Organoids: Progress and Challenges” (Cell Stem Cell) — comprehensive review of organoid potential and limitations.
• Humphreys, “Mechanisms of Renal Regeneration” (Annual Review of Physiology) — context on kidney healing mechanisms important for engineering.
• Campbell & Humphreys, “Regenerative Therapies for Kidney Disease” (Nature Reviews Nephrology) — clinical implications and future directions.

Bioprinting and tissue fabrication

• Derby, “Printing and Prototyping of Tissues and Organs” (Science) — overview of 3D bioprinting approaches.
• Mandrycky et al, “3D Bioprinting for Engineering Complex Tissues” (Biotechnology Advances) — broader context on fabrication technologies.

Journals with active contributions

These journals frequently publish research on kidney regeneration, organoids, stem cells, and tissue engineering:

• Nature Biotechnology
• Cell Stem Cell
• Science Translational Medicine
• Tissue Engineering
• Biomaterials
• BMC Nephrology
• Nature Reviews Nephrology
• Journal of the American Society of Nephrology

Searching within these titles for terms such as kidney organoid stem cell, bioprinting renal tissue, and bioengineered kidney vascularization yields many relevant studies.

Key institutional and clinical resources

Academic labs & research groups

• Harvard Stem Cell Institute (HSCI) — kidney organoid research and pluripotent stem cell differentiation.
• University of California Davis Regenerative Medicine Program — organ engineering and translational models.
• Wyss Institute at Harvard — bioprinting and organ-on-chip platforms.

Clinical and translational centers

• KidneyX Innovation Accelerator (NIH + ASN initiative) — focused on disruptive technologies in kidney care.
• Regenerative Medicine Centres in major universities (Stanford, MIT, UCSF) — regularly host lectures, webinars, and open access publications.

Theses and textbooks

For structured learning, consult these texts:

• Textbook of Organ Transplantation — chapters on tissue engineering and organ replacement strategies.
• Regenerative Medicine and Tissue Engineering handbooks — comprehensive background on scaffolds, cells, growth factors, and manufacturing.

Useful search terms for deep literature dives

Use these queries on academic databases (PubMed, Google Scholar, Web of Science):

• kidney organoid human iPS cells
• decellularized kidney scaffold transplantation
• 3D bioprinting vasculature renal tissue
• functional kidney tissue engineering review
• bioartificial kidney device clinical trial

Databases and filtering tips

PubMed

• Start with broad phrases like kidney organoid kidney bioengineering then refine by year to capture the latest work.

ClinicalTrials.gov

• Many regenerative strategies progress through preclinical and early clinical phases; searching for bioengineered kidney, kidney tissue scaffold, or renal cell therapy shows ongoing studies.
• YouTube talks from major conferences (e.g., ISSCR, ASN Kidney Week, TERMIS) on organoid technology.
• Recorded seminars from universities on stem cell based therapies.

Kidney organoid development & functional models

🔹 “Application progress of bio-manufacturing technology in kidney organoids”
A 2025 review covering organoid models, vascularization challenges, organ-on-chip and 3D printing technology as they apply to kidney organoids. This is a very current overview of where the field stands in biofabrication and functional tissue growth.

🔹 “Kidney Organoids: Current Advances and Applications”
A comprehensive review (2025) on the state of kidney organoid research, summarising differentiation, structure and functional relevance as research tools for modeling kidney development and disease.

🔹 “Recent advances in extracellular matrix manipulation for kidney organoid research”
Looks at how manipulating the extracellular matrix affects organoid development, structure, and function — an important step toward making more mature, functional tissues.

🔹 “Translating Organoids into Artificial Kidneys”
An accessible paper reviewing how organoids could become functional engineered kidneys, including barriers to clinical translation.

Engineering, bioprinting & tissue fabrication

🔹 “A review of 3D bioprinting for organoids”
Discusses 3D bioprinting technologies, bioinks, and the potential of printed organoids to model organ functions.

🔹 “Renal tissue engineering for regenerative medicine using polymers and hydrogels”
Explores biomaterials used in kidney tissue engineering and how they support cell growth and kidney-like structure formation.

🔹 “A critical review of current progress in 3D kidney biomanufacturing”
A review of 3D biomanufacturing for kidneys, exploring current limitations and why full organ fabrication is still in early stages.

Vascularization studies

🔹 “Strategies for improving vascularization in kidney organoids”
A detailed open-access review on how researchers are trying to induce blood vessel formation within kidney organoids — one of the biggest obstacles to making mature functional organs.

🔹 “Stem cell-derived kidney organoids: engineering the vasculature”
A foundational review on approaches to vascularise organoids to improve maturation and potential clinical relevance.

Cutting edge research example

🔹 “Engineering scalable vascularized kidney organoids” (npj Biomedical Innovations)
A recent experimental study showing methods to produce large numbers of vascularised nephron structures — a practical step toward tissue that could one day be implantable.

Academic databases

• PubMed / PubMed Central — search terms to try: “kidney organoid functional development”, “renal tissue engineering review”, “3D printing vascularised tissue”, “bioengineered kidney translational research”

Practical tips for your deep dive

📌 Start with recent reviews (2024-2025) like the kidney organoid progress and bio-manufacturing application papers above to get context on limitations and opportunities for translation.

📌 Pair reviews with a few experimental studies such as scalable vascular organoid research — this bridges theory and practice.

📌 Track citations out from key papers — often the most valuable sources are cited works that you discover through reviews.